DK0776898T3 - Fremgangsmådeforbedring ved syntesen af N-[3-(3-cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-N-ethyl-acetamid - Google Patents

Fremgangsmådeforbedring ved syntesen af N-[3-(3-cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-N-ethyl-acetamid

Info

Publication number
DK0776898T3
DK0776898T3 DK96308630T DK96308630T DK0776898T3 DK 0776898 T3 DK0776898 T3 DK 0776898T3 DK 96308630 T DK96308630 T DK 96308630T DK 96308630 T DK96308630 T DK 96308630T DK 0776898 T3 DK0776898 T3 DK 0776898T3
Authority
DK
Denmark
Prior art keywords
cyanopyrazolo
pyrimidin
acetamide
phenyl
synthesis
Prior art date
Application number
DK96308630T
Other languages
English (en)
Inventor
Padmanathan Thurairajah
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Application granted granted Critical
Publication of DK0776898T3 publication Critical patent/DK0776898T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
DK96308630T 1995-12-01 1996-11-28 Fremgangsmådeforbedring ved syntesen af N-[3-(3-cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-N-ethyl-acetamid DK0776898T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US785995P 1995-12-01 1995-12-01

Publications (1)

Publication Number Publication Date
DK0776898T3 true DK0776898T3 (da) 2003-02-24

Family

ID=21728482

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96308630T DK0776898T3 (da) 1995-12-01 1996-11-28 Fremgangsmådeforbedring ved syntesen af N-[3-(3-cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-N-ethyl-acetamid

Country Status (25)

Country Link
US (1) US5714607A (da)
EP (1) EP0776898B1 (da)
JP (1) JP4112032B2 (da)
KR (1) KR100439282B1 (da)
CN (1) CN1057525C (da)
AR (1) AR004822A1 (da)
AT (1) ATE227290T1 (da)
AU (1) AU718310B2 (da)
BR (1) BR9605760A (da)
CA (1) CA2191647C (da)
CY (1) CY2440B1 (da)
CZ (1) CZ292253B6 (da)
DE (1) DE69624657T2 (da)
DK (1) DK0776898T3 (da)
ES (1) ES2184844T3 (da)
HU (1) HU226398B1 (da)
IL (1) IL119710A (da)
MX (1) MX9605974A (da)
NO (1) NO307181B1 (da)
NZ (1) NZ299848A (da)
PT (1) PT776898E (da)
RU (1) RU2178415C2 (da)
SK (1) SK281807B6 (da)
TW (1) TW382629B (da)
ZA (1) ZA9610008B (da)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6399621B1 (en) 1999-08-10 2002-06-04 American Cyanamid Company N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1, 5-α]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto
US20030091632A1 (en) * 1999-08-26 2003-05-15 Neurocrine Biosciences, Inc. Controlled-release sedative-hypnotic compositions and methods related thereto
US6485746B1 (en) 2000-08-25 2002-11-26 Neurocrine Biosciences, Inc. Controlled-release sedative-hypnotic compositions and methods related thereto
US6384221B1 (en) 1999-09-02 2002-05-07 Neurocrine Biosciences, Inc. Polymorphs of N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-α]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto
CN1610682A (zh) * 2000-08-03 2005-04-27 Wyeth公司 扎来普隆多晶型物及其制备方法
EP1526136A1 (en) * 2000-08-03 2005-04-27 Wyeth Polymorphs of zaleplon and methods for the preparation thereof
AR029780A1 (es) 2000-12-13 2003-07-16 Gador Sa Procedimiento mejorado para la obtencion de n-[3(3-ciano-pirazolo[1,5-a]pirimidin-7-il)fenil]-n-etil-acetamida
US20050032818A1 (en) * 2001-06-12 2005-02-10 Entire Interest N-[3-(3-cyanopyrazolo[1,5-a]pyrimidin-5-yl)phenyl]-N-ethylacetamide and crystalline forms of zaleplon
IL159281A0 (en) * 2001-06-12 2004-06-01 Biogal Pharmaceutical Co Ltd Process for the production of n-[3-(3-cyanopyrazolo{1,5-a} pyrimidin-7-yl) phenyl]-n-ethylacetamide (zaleplon)
HUP0402253A3 (en) * 2001-08-01 2005-12-28 Teva Gyogyszergyar Zartkoeruee Process for the purification of n-[3-(3-cyanopyrazolo[1,5-a]pyrimidin-7-yl)-phenyl]-n-ethylacetamide(zaleplon) and the preparation of its novel crystalline forms and pharmaceutical compositions containing the latters
ATE368667T1 (de) * 2002-02-14 2007-08-15 Cilag Ag Verfahren zur herstellung von n-ethyl-n-(3-(3- cyanopyrazolo-(1,5-a)-pyrimidin-7-yl)phenyl)- acetamid
EP1490068A1 (en) * 2002-02-15 2004-12-29 Biogal Gyogyszergyar Rt. Powder composition comprising zaleplon of defined particle size distribution and pharmaceutical products made therefrom
PL207322B1 (pl) * 2002-05-14 2010-11-30 Adamed Społka Z Ograniczoną Odpowiedzialnością Sposób wytwarzania zaleplonu
DE112004001615T5 (de) * 2003-09-04 2006-06-14 Cipla Ltd. Zaleplon-Synthese
US20050176680A1 (en) 2003-12-11 2005-08-11 Sepracor, Inc. Combination of sedative and a neurotransmitter modulator, and methods for improving sleep quality and treating depression
CA2553465A1 (en) * 2004-01-14 2005-08-04 Mallinckrodt Inc. Two-phase method for the synthesis of selected pyrazolopyrimidines
HUP0400325A3 (en) * 2004-02-02 2005-11-28 Richter Gedeon Vegyeszet Pure n-[3-(-cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-n-ethyl-acetamide, process for its preparation and intermediates
AU2005215376B2 (en) 2004-02-18 2011-01-20 Sunovion Pharmaceuticals Inc. Dopamine-agonist combination therapy with sedatives for improving sleep quality
WO2006070244A2 (en) * 2004-11-22 2006-07-06 Bakulesh Mafatlal Khamar A process for the preparation of zaleplon
TW200815428A (en) * 2006-08-15 2008-04-01 Wyeth Corp Oxazolidone derivatives as PR modulators
US7538107B2 (en) 2006-08-15 2009-05-26 Wyeth Oxazinan-2-one derivatives useful as PR modulators
US7652018B2 (en) * 2006-08-15 2010-01-26 Wyeth Llc Imidazolidin-2-one derivatives useful as PR modulators
US7649007B2 (en) * 2006-08-15 2010-01-19 Wyeth Llc Oxazolidine derivatives as PR modulators
WO2008068600A2 (en) * 2006-12-06 2008-06-12 Orchid Chemicals & Pharmaceuticals Limited An improved process for the preparation of zaleplo
CZ301145B6 (cs) 2008-07-31 2009-11-18 Farmak, A. S. Zpusob prípravy N-(1-benzo[b]thien-2-ylethyl)-N-hydroxymocoviny
CN102816163A (zh) * 2012-08-20 2012-12-12 四川禾邦阳光制药股份有限公司 扎来普隆的新晶型及制备方法
CN112694336B (zh) * 2020-12-29 2021-11-16 哈尔滨工业大学 一种高纯α相氮化硅纤维毡的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4281000A (en) * 1979-07-09 1981-07-28 American Cyanamid Company Substituted pyrazolo (1,5-a)pyrimidines and their use as anxiolytic agents
US4626538A (en) * 1983-06-23 1986-12-02 American Cyanamid Company [7-(3-disubstituted amino)phenyl]pyrazolo[1,5-a]pyrimidines
US4521422A (en) * 1983-06-23 1985-06-04 American Cyanamid Company Aryl and heteroaryl[7-(aryl and heteroaryl)pyrazolo[1,5-a]pyrimidin-3-yl]methanones
NZ208554A (en) * 1983-06-23 1987-06-30 American Cyanamid Co (aryl and heteroaryl)-(7-(aryl and heteroaryl)-pyrazolo (1,5-a) pyrimidin-3-yl)-methanone derivatives and pharmaceutical compositions
JPS62270584A (ja) * 1986-04-28 1987-11-24 Yoshitomi Pharmaceut Ind Ltd ４，７−ジヒドロピラゾロ〔１，５−ａ〕ピリミジン誘導体
GB9321162D0 (en) * 1993-10-13 1993-12-01 Boots Co Plc Therapeutic agents

Also Published As

Publication number Publication date
HU9603275D0 (en) 1997-01-28
CN1057525C (zh) 2000-10-18
NO965084L (no) 1997-06-02
CZ292253B6 (cs) 2003-08-13
CA2191647A1 (en) 1997-06-02
HUP9603275A2 (en) 1997-08-28
JPH09216885A (ja) 1997-08-19
CN1163893A (zh) 1997-11-05
EP0776898A1 (en) 1997-06-04
SK281807B6 (sk) 2001-08-06
AU7409196A (en) 1997-06-05
CZ350596A3 (en) 1997-09-17
CA2191647C (en) 2005-01-25
IL119710A0 (en) 1997-02-18
NO965084D0 (no) 1996-11-28
AU718310B2 (en) 2000-04-13
US5714607A (en) 1998-02-03
TW382629B (en) 2000-02-21
KR970042543A (ko) 1997-07-24
AR004822A1 (es) 1999-03-10
IL119710A (en) 1999-11-30
ES2184844T3 (es) 2003-04-16
DE69624657T2 (de) 2003-08-21
SK153696A3 (en) 1997-11-05
RU2178415C2 (ru) 2002-01-20
JP4112032B2 (ja) 2008-07-02
PT776898E (pt) 2003-02-28
DE69624657D1 (de) 2002-12-12
EP0776898B1 (en) 2002-11-06
HU226398B1 (en) 2008-11-28
HUP9603275A3 (en) 1997-10-28
MX9605974A (es) 1998-04-30
ZA9610008B (en) 1998-08-28
ATE227290T1 (de) 2002-11-15
BR9605760A (pt) 1998-08-25
CY2440B1 (en) 2004-11-12
NZ299848A (en) 1998-09-24
KR100439282B1 (ko) 2004-08-31
NO307181B1 (no) 2000-02-21

Similar Documents

Publication Publication Date Title
DK0776898T3 (da) Fremgangsmådeforbedring ved syntesen af N-[3-(3-cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-N-ethyl-acetamid
PL320555A1 (en) Method of obtaining 5-[2-ethoxy-5-(4-methylpierazin-1-ylsulphonyl)phenyl]-1-methyl-3-n-propylo-1,6-dihydro-7h-pyrazole[4,3-d]pyrimidin-7-one and novel intermediate compounds
NO973982D0 (no) Fremgangsmåte for fremstilling av heteromultimere polypeptider
NO20001938L (no) Fremgangsmate for fremstilling av aryloksy-alkyl-dialkylaminer
DE69905652D1 (de) Direkte Herstellung von Pyrrolo-(3,4-c)pyrrolpigmenten
NO994943D0 (no) Fremgangsmåte ved fremstilling av pyrazolo[4,3-d]pyrimidin-7-oner og mellomproduktet for disse
NO962320L (no) Tricykliske 5,6-dihydro-9H-pyrazolo [3,4cÅ-1,2,4-triazolo [4,3-aÅ pyridiner
BR9611339A (pt) Processo de preparação de 1,3-propanediol
IL160076A0 (en) Process for purifying n-[3-(3-cyanopyrazolo{1,5-a} pyrimidin-7-yl) phenyl]-n-ethylacetamide (zaleplon) and crystalline forms of zaleplon accessible with the process
DE69624959D1 (de) Herstellung von Pentafluorphenylverbindungen
PL372942A1 (en) Process for the production of n-[3-(3-cyanopyrazolo[1,5-a] pyrimidin-7-yl)phenyl]-n-ethylacetamide (zaleplon)
HUP0002159A3 (en) Process for preparing intermediates of pesticidally active compounds, the novel intermediates using in this process and preparation thereof
AU3207297A (en) Process for the production of 8-chloro-6-(2-fluorophenyl)-1-methyl-4h-imidazo{1,5-a}benzod iazepine
NO20005104D0 (no) FremgangsmÕte ved fremstillingen av pyrazolo[4,3-d]pyrimidin- 7-on-3-pyridylsulfonylforbindelser og intermediater derav
NO941967D0 (no) Fremgangsmåte for enantioselektivsyntesen for mellomprodukter anvendt i fremstillingen av fysostigmin
NO980316D0 (no) Fremgangsmåte for fremstilling av polymerisater av N-vinylkarprolaktam
NO982503D0 (no) FremgangsmÕte ved fremstilling av dioksoazabicykloheksaner
FI102963B1 (fi) Menetelmä 2-butyyli-2-etyyli-1,3-propaanidiolin valmistamiseksi
DE69813388D1 (de) Verfahren zur Herstellung von 2,4-Oxazolidindion
FI960790A0 (fi) Menetelmä fluoreenibisfenolin valmistamiseksi
GB9621492D0 (en) Novel cell surface protein compounds
FI962389A0 (fi) Menetelmä alkoholien valmistamiseksi